HomeNewsIndiaCoronavirus pandemic: TRAI grants six weeks additional time to telcos to file monthly, quarterly reports

Coronavirus pandemic: TRAI grants six weeks additional time to telcos to file monthly, quarterly reports

TRAI considered the request of COAI in view of the prevailing circumstances, and agreed to extend the time to submit monthly and quarterly reports due in April by six weeks

March 29, 2020 / 19:59 IST
Story continues below Advertisement

Telecom regulator TRAI has given six weeks additional time to telecom companies to file monthly and quarterly reports that are otherwise due in April, a senior official said on Sunday.

The decision comes within days of industry body COAI writing to the Telecom Regulatory Authority of India (TRAI) for granting additional time to telecom companies to file such reports, citing massive efforts being undertaken by them to overcome "numerous operational challenges" in order to keep vital networks up and running amid the 21-day nationwide lockdown to counter the spread of coronavirus.

Story continues below Advertisement

"TRAI considered the request of COAI in view of the prevailing circumstances, and agreed to extend the time to submit monthly and quarterly reports due in April by six weeks," TRAI Secretary SK Gupta said.

In a letter addressed to TRAI Chairman RS Sharma, the Cellular Operators' Association of India (COAI) on March 26 had said that it is "extremely difficult for our members to submit various monthly and quarterly reports on the due date as per the requirements of TRAI as most of these reports require circle wise compilation and their compilation in the current environment will not be possible."

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show